600993.SH
Mayinglong Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 22.73
−1.22%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 14.67x
- P/E 2027E
- 13.22x
- P/E 2028E
- 11.93x
- P/S forward
- 9.68x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.85x
- PEG TTM
- 2.43x
- Price / book
- 2.28x
- Price / sales
- 2.50x
- Price / cash flow
- 14.25x
Enterprise value
- Enterprise value
- CNY 9.0B
- EV / sales
- 2.31x
- EV / EBITDA
- 11.39x
- EV / EBIT
- 12.37x
- Market cap
- CNY 9.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026